close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar46061Point90
Implied share price

Buy Undervalued by 230309400.0%

5% margin of safety What's this?

EV / Revenue
Use Average
OSCI
Oscient Pharmaceuticals Corporation
KUN
China Shenghuo Pharmaceutical Hldg, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
SNY
Sanofi SA (ADR)
Change
AMGN
Amgen, Inc.
Change
20915.23 2.13 27840.41 14.37 2.11 7.31
All amounts in millions
from last financial year
         
Implied Share Price $46061.90 $46932.12 $155290.65 $527436.98 $513494.93
Market Cap 0 1,229,412 156,463 127,051 123,715
Net Debt 184 20 4,504 6,333 12,727
Enterprise Value (EV) 185 1,229,432 160,967 70,203 136,442
Revenue 86 44 11,201 33,306 18,676
Balance Sheet          
Total Assets 174 58 22,496 96,055 66,125
Total Liabilities 255 56 11,127 39,151 44,029
Shareholders Equity -81 2 11,369 56,904 22,096.0

Where are the EBIT and EBITDA figures?

Certain companies and those in specific industries (for example insurance) do not report financial results at the EBIT or EBITDA line. For these companies where Valuecruncher does not have EBIT or EBITDA numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

To learn more about comparison analysis, please read our guide to comparison analysis

Comments

No comments yet. Login to comment.